Back to Search
Start Over
Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic.
- Source :
-
The British journal of psychiatry : the journal of mental science [Br J Psychiatry] 2020 Sep; Vol. 217 (3), pp. 471-474. - Publication Year :
- 2020
-
Abstract
- Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.
- Subjects :
- Betacoronavirus
COVID-19
Humans
Inappropriate Prescribing prevention & control
Medication Therapy Management standards
Mental Health Services trends
Netherlands epidemiology
Patient Selection
SARS-CoV-2
Telemedicine methods
Anxiety etiology
Anxiety therapy
Coronavirus Infections epidemiology
Coronavirus Infections psychology
Mental Disorders epidemiology
Mental Disorders therapy
Pandemics
Pneumonia, Viral epidemiology
Pneumonia, Viral psychology
Practice Patterns, Physicians' standards
Psychotherapy methods
Psychotherapy trends
Psychotropic Drugs therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1472-1465
- Volume :
- 217
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- The British journal of psychiatry : the journal of mental science
- Publication Type :
- Academic Journal
- Accession number :
- 32362299
- Full Text :
- https://doi.org/10.1192/bjp.2020.92